(SPFI) South Plains Financial - Overview
Stock: Deposits, Loans, Mortgages, Trust Services, Investments
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.10% |
| Yield on Cost 5y | 3.57% |
| Yield CAGR 5y | 19.90% |
| Payout Consistency | 100.0% |
| Payout Ratio | 14.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.7% |
| Relative Tail Risk | -6.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 9.73 |
| Character TTM | |
|---|---|
| Beta | 0.669 |
| Beta Downside | 0.636 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.52% |
| CAGR/Max DD | 0.60 |
Description: SPFI South Plains Financial December 26, 2025
South Plains Financial, Inc. (NASDAQ: SPFI) is a bank holding company that operates City Bank, delivering a full suite of commercial and consumer banking services to small- and medium-sized enterprises and individual customers in Texas and surrounding markets.
Its core deposit franchise includes demand accounts, interest-bearing products, savings accounts, and certificates of deposit, while its lending platform spans commercial real-estate, agricultural, energy, construction, and consumer loans-including 1-4-family residential mortgages and auto financing.
Beyond traditional banking, the firm offers trust and wealth-management solutions such as revocable and irrevocable trusts, charitable trusts, self-directed IRAs, and a range of investment products (money-market funds, mutual funds, annuities, and municipal bonds).
Key recent metrics (Q2 2024) show a loan portfolio of roughly **$2.3 billion**, a deposit base of **$2.9 billion**, a loan-to-deposit ratio of **79 %**, and a net interest margin of **3.8 %**, supporting a **ROE of ~10.5 %**-all above the regional-bank median.
Sector-level drivers that materially affect SPFI include the Federal Reserve’s interest-rate trajectory (which influences net interest margin), Texas’s strong population growth (fueling retail-bank demand), and the cyclical nature of agricultural and energy loan performance tied to commodity price volatility.
For a deeper, data-rich look at how SPFI’s valuation stacks up against peers, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 58.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: -1189 % < 20% (prev -1050 %; Δ -138.7% < -1%) |
| CFO/TA 0.02 > 3% & CFO 69.2m > Net Income 58.5m |
| Net Debt (-58.3m) to EBITDA (59.3m): -0.98 < 3 |
| Current Ratio: 0.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.0m) vs 12m ago -0.96% < -2% |
| Gross Margin: 73.04% > 18% (prev 0.65%; Δ 7238 % > 0.5%) |
| Asset Turnover: 5.78% > 50% (prev 6.69%; Δ -0.90% > 0%) |
| Interest Coverage Ratio: 0.65 > 6 (EBITDA TTM 59.3m / Interest Expense TTM 85.0m) |
Altman Z'' -3.88
| A: -0.67 (Total Current Assets 625.9m - Total Current Liabilities 3.62b) / Total Assets 4.48b |
| B: 0.10 (Retained Earnings 434.2m / Total Assets 4.48b) |
| C: 0.01 (EBIT TTM 55.0m / Avg Total Assets 4.36b) |
| D: 0.10 (Book Value of Equity 402.8m / Total Liabilities 3.99b) |
| Altman-Z'' Score: -3.88 = D |
Beneish M -3.09
| DSRI: 1.12 (Receivables 21.7m/21.7m, Revenue 252.0m/283.1m) |
| GMI: 0.89 (GM 73.04% / 65.35%) |
| AQI: 1.02 (AQ_t 0.85 / AQ_t-1 0.83) |
| SGI: 0.89 (Revenue 252.0m / 283.1m) |
| TATA: -0.00 (NI 58.5m - CFO 69.2m) / TA 4.48b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of SPFI shares?
Over the past week, the price has changed by +4.15%, over one month by +11.79%, over three months by +19.39% and over the past year by +19.77%.
Is SPFI a buy, sell or hold?
- StrongBuy: 1
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SPFI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.8 | 8.2% |
| Analysts Target Price | 46.8 | 8.2% |
| ValueRay Target Price | 50.6 | 17.1% |
SPFI Fundamental Data Overview January 31, 2026
P/S = 3.2218
P/B = 1.3369
Revenue TTM = 252.0m USD
EBIT TTM = 55.0m USD
EBITDA TTM = 59.3m USD
Long Term Debt = 110.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.64m USD (from shortTermDebt, last fiscal year)
Debt = 110.4m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -58.3m USD (from netDebt column, last quarter)
Enterprise Value = 150.4m USD (665.9m + Debt 110.4m - CCE 625.9m)
Interest Coverage Ratio = 0.65 (Ebit TTM 55.0m / Interest Expense TTM 85.0m)
EV/FCF = 2.37x (Enterprise Value 150.4m / FCF TTM 63.6m)
FCF Yield = 42.27% (FCF TTM 63.6m / Enterprise Value 150.4m)
FCF Margin = 25.23% (FCF TTM 63.6m / Revenue TTM 252.0m)
Net Margin = 23.20% (Net Income TTM 58.5m / Revenue TTM 252.0m)
Gross Margin = 73.04% ((Revenue TTM 252.0m - Cost of Revenue TTM 67.9m) / Revenue TTM)
Gross Margin QoQ = none% (prev 70.29%)
Tobins Q-Ratio = 0.03 (Enterprise Value 150.4m / Total Assets 4.48b)
Interest Expense / Debt = 18.55% (Interest Expense 20.5m / Debt 110.4m)
Taxrate = 20.08% (3.83m / 19.1m)
NOPAT = 43.9m (EBIT 55.0m * (1 - 20.08%))
Current Ratio = 0.17 (Total Current Assets 625.9m / Total Current Liabilities 3.62b)
Debt / Equity = 0.22 (Debt 110.4m / totalStockholderEquity, last quarter 493.8m)
Debt / EBITDA = -0.98 (Net Debt -58.3m / EBITDA 59.3m)
Debt / FCF = -0.92 (Net Debt -58.3m / FCF TTM 63.6m)
Total Stockholder Equity = 467.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.34% (Net Income 58.5m / Total Assets 4.48b)
RoE = 12.51% (Net Income TTM 58.5m / Total Stockholder Equity 467.4m)
RoCE = 9.52% (EBIT 55.0m / Capital Employed (Equity 467.4m + L.T.Debt 110.4m))
RoIC = 7.95% (NOPAT 43.9m / Invested Capital 552.8m)
WACC = 9.30% (E(665.9m)/V(776.3m) * Re(8.38%) + D(110.4m)/V(776.3m) * Rd(18.55%) * (1-Tc(0.20)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.04%
[DCF Debug] Terminal Value 72.86% ; FCFF base≈61.9m ; Y1≈59.7m ; Y5≈58.9m
Fair Price DCF = 54.72 (EV 833.2m - Net Debt -58.3m = Equity 891.5m / Shares 16.3m; r=9.30% [WACC]; 5y FCF grow -4.78% → 2.90% )
EPS Correlation: 6.16 | EPS CAGR: 3.89% | SUE: 0.22 | # QB: 0
Revenue Correlation: 3.84 | Revenue CAGR: -13.24% | SUE: 1.61 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.86 | Chg30d=+0.045 | Revisions Net=-1 | Analysts=4
EPS current Year (2026-12-31): EPS=3.84 | Chg30d=+0.210 | Revisions Net=+2 | Growth EPS=+11.6% | Growth Revenue=+17.3%
EPS next Year (2027-12-31): EPS=4.20 | Chg30d=+0.225 | Revisions Net=+2 | Growth EPS=+9.3% | Growth Revenue=+9.4%